executive appointment
Myriad Genetics Q2 Revenues Decrease 10 Percent; CEO Mark Capone Steps Down
The company attributed its revenue shortfall to billing issues in the prenatal testing business and announced that CFO Bryan Riggsbee will be interim CEO.
Accelerate Diagnostics Q2 Sales Miss Estimate, But Analysts Cheer COO Appointment
The appointment of a former Roche executive as the firm's new COO is viewed as a significant event for a firm still in the early stages of driving adoption of its Pheno system.
Prognos, an AI startup, wants to "beat the MD" at predicting disease, according to the company's newly hired chief data scientist.